Textbook Outcome/Textbook Oncological Outcome for Pancreatic Cancer Treatment.

In Vivo · 2026 · PMC13321937 · PMID 42379736

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally significantp =0.053so close (0.05 < p ≤ 0.1)

There was also a marginally significant difference in recurrence-free survival (RFS), with median RFS of 19 months in the TOO-achievement group compared to 13 months in the non-achievement group ( p =0.053).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.